Biotech

All Articles

Galapagos' stock up as fund shows intent to form its advancement

.Galapagos is coming under added stress from clients. Having actually developed a 9.9% stake in Gala...

Cell- centered Sana scoops first CSO-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of notable management hirings, shootings and ...

Allist pays Jacobio $21M, landing task in Chinese KRAS ethnicity

.Shanghai Allist Pharmaceuticals has purchased itself a starring character in China's KRAS market, s...

ReNeuron leaving behind purpose substitution after overlooking fundraising target

.ReNeuron has signed up with the long checklist of biotechs to leave behind London's purpose stock m...

MBX apply for IPO to take challenger to Ascendis into phase 3

.MBX Biosciences has added to the current spurt of IPO filings. The biotech, which submitted its own...

FDA extends probe right into Lykos' MDMA trials: WSJ

.For Lykos Therapies as well as the provider's potential MDMA-assisted treatment for post-traumatic ...

Gene editor Volume giving up 131 employees

.Just days after genetics editor Volume Biosciences announced hidden working cuts, a clearer image i...

Repare gives up 25% of personnel as biotech stops preclinical R&ampD

.Repare Therapeutics is laying off an one-fourth of its staff as the oncology biotech downsize its p...

J &amp J files for FDA approval of $6.5 B autoimmune drug

.Johnson &amp Johnson has actually taken an additional measure toward noticing a return on its own $...

Gain's phase 1 win leads technique to verify Parkinson's drug's worth

.Gain Therapeutics has established its own sights on proving the performance of its own Parkinson's ...